Journal of Health Care Compliance
Looking Ahead: DOJ Enforcement Priorities in 2025
November – December 2024
In 2024, the Department of Justice (DOJ) continued to emerge from a pandemic lull and return to vigorous enforcement of the False Claims Act (FCA) — indeed in February, DOJ announced that it had issued a record 1,504 civil investigative demands in fiscal year 2023, and its current activity levels suggest another record-breaking year. In 2025, the healthcare industry can expect that DOJ will continue to prioritize investigating alleged fraud, waste, and abuse in the industry, with particular attention paid to private equity investment, the Anti-Kickback Statute (AKS), pandemic relief fraud, and cyber fraud.
関連公式ブログ
得意分野
Suggested News & Insights
DOJ and HHS Launch Healthcare FCA Self-Disclosure Pilot Program with Fixed Repayment MultiplierOctober 22, 2026HHS Secretary Extends HHS-OIG Exclusion Authority to CMS, Expanding the Administration's Anti-Fraud CampaignOctober 19, 2026DOJ Fraud Division and HHS-OIG Announce Joint Self-Disclosure Policy, Directing Healthcare Companies to Bring Potential Criminal Matters to DOJ FirstOctober 16, 2026Court Grants Summary Judgment in Kickback-Based FCA Case, Holding Relator Failed to Prove Remuneration or WillfulnessOctober 7, 2026False Claims Act Risk on the RadarTuesday, October 6, 2026Court Holds Insurer Must Cover FCA Settlement Despite “Fraudulent Acts” ExclusionOctober 2, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
